Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
1 Stock That Should Be in Every Investor's Portfolio
06:15am, Monday, 15'th Sep 2025
It's not often that something as influential as an effective weight loss drug comes on the market. Eli Lilly (LLY -0.20%) has that product.
2 no-brainer stocks to buy for end of 2025
02:52pm, Sunday, 14'th Sep 2025
As investors position their portfolios for the next year, certain companies stand out for their strong fundamentals and long-term growth drivers.
3 Monster Stocks to Hold for the Next 5 Years
07:45am, Sunday, 14'th Sep 2025
The past five years have been rocky, to say the least. Investors have dealt with a worldwide pandemic, political tensions, trade wars, actual wars, economic troubles, market crashes, and more.
2 Beaten-Down Stocks to Buy and Hold Forever
07:45am, Saturday, 13'th Sep 2025
Apple (AAPL 1.82%) and Eli Lilly (LLY -0.20%) share several similarities. Both are long-standing leaders in their respective industries, having produced market-beating returns over the past 10 years,
3 No-Brainer Dividend Stocks to Buy in September
06:42am, Saturday, 13'th Sep 2025
Some decisions are tough to make. Others are so easy that they don't require much thought and are practically no-brainers.
Eli Lilly, Novo Nordisk prepare to face off in the next obesity drug battleground
12:13pm, Friday, 12'th Sep 2025
Eli Lilly and Novo Nordisk are both preparing to launch obesity pills in the U.S. next year. Lilly expects results from a head-to-head trial of its pill orforglipron versus Novo's oral semaglutide in
1 Super Stock Down More Than 20% to Buy Hand Over Fist, According to Wall Street
04:44am, Friday, 12'th Sep 2025
For a while, it seemed that nothing could go wrong for Eli Lilly (LLY 0.23%). Surging sales for Lilly's type 2 diabetes drug Mounjaro and great expectations for its obesity drug Zepbound fueled massiv
Eli Lilly loses appeal of $183.7 million Medicaid fraud award
01:30pm, Thursday, 11'th Sep 2025
A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer and pharmacist who accused the drugmaker of defrauding Medicaid.
Lilly to participate in Bernstein's 2nd Annual Healthcare Forum
10:00am, Thursday, 11'th Sep 2025
INDIANAPOLIS , Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025.
2 Monster Stocks to Hold for the Next 5 Years
04:20am, Thursday, 11'th Sep 2025
What's a monster stock? In my book, it's a company that's already delivered enormous growth to investors, and considering opportunities ahead, this player should continue to roar higher in the years t
Oxford Industries says new Lilly Pulitzer offerings are winning over shoppers, but its Tommy Bahama line is lagging
05:57pm, Wednesday, 10'th Sep 2025
Resort-style clothing maker Oxford Industries Inc. on Wednesday offered up mixed second-quarter results and third-quarter expectations, and said that while new Lilly Pulitzer offerings were attracting
The Big 3: TGT, LLY, C
01:01pm, Wednesday, 10'th Sep 2025
Target (TGT) will continue to face challenges with a weakening economy hitting the retail industry, says @Theotrade's Don Kaufman. He says the stock can continue to stumble if it slides below $90.
5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds
12:11pm, Wednesday, 10'th Sep 2025
In the Large-Cap Pharmaceuticals industry, Lilly, J&J, Novartis, Pfizer and Bayer are worth retaining amid macro pressure and rising innovation.
Eli Lilly (LLY) Just Reclaimed the 50-Day Moving Average
10:31am, Wednesday, 10'th Sep 2025
From a technical perspective, Eli Lilly (LLY) is looking like an interesting pick, as it just reached a key level of support. LLY recently overtook the 50-day moving average, and this suggests a short
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Sept 2025)
10:20am, Wednesday, 10'th Sep 2025
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%.
